Selected research
Industry Research
Lipids in Human Nutrition Industry Research Report 2026
Market perspective
The global Lipids in Human Nutrition market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lipids in Human Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lipids in Human Nutrition is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lipids in Human Nutrition is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lipids in Human Nutrition include DSM, Polaris, ADM, BASF, FMC Corporation, Lonza Group AG, Omega Protein Corporation and Cargill, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lipids in Human Nutrition market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lipids in Human Nutrition Market by Company
DSM
Polaris
ADM
BASF
FMC Corporation
Lonza Group AG
Omega Protein Corporation
Cargill
Lipids in Human Nutrition Segment by Type
Triglycerides
Phospholipids
Other
Lipids in Human Nutrition Segment by Application
Dietary Supplements
Functional Nutrition
Sports Nutrition
Baby Nutrition
Other
Lipids in Human Nutrition Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipids in Human Nutrition market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipids in Human Nutrition and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipids in Human Nutrition.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lipids in Human Nutrition manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lipids in Human Nutrition by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lipids in Human Nutrition in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Triglycerides
- Phospholipids
- Other
Applications
- Dietary Supplements
- Functional Nutrition
- Sports Nutrition
- Baby Nutrition
- Other
Companies covered
- DSM
- Polaris
- ADM
- BASF
- FMC Corporation
- Lonza Group AG
- Omega Protein Corporation
- Cargill
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lipids in Human Nutrition Market Size (2021-2032)
- 2.2.2 Global Lipids in Human Nutrition Sales (2021-2032)
- 2.2.3 Global Lipids in Human Nutrition Market Average Price (2021-2032)
- 2.3 Lipids in Human Nutrition by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Triglycerides
- 2.3.3 Phospholipids
- 2.3.4 Other
- 2.4 Lipids in Human Nutrition by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dietary Supplements
- 2.4.3 Functional Nutrition
- 2.4.4 Sports Nutrition
- 2.4.5 Baby Nutrition
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lipids in Human Nutrition Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lipids in Human Nutrition Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Lipids in Human Nutrition Revenue of Manufacturers (2021-2026)
- 3.4 Global Lipids in Human Nutrition Average Price by Manufacturers (2021-2026)
- 3.5 Global Lipids in Human Nutrition Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lipids in Human Nutrition, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lipids in Human Nutrition, Product Type & Application
- 3.8 Global Manufacturers of Lipids in Human Nutrition, Established Date
- 3.9 Global Lipids in Human Nutrition Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DSM
- 4.1.1 DSM Company Information
- 4.1.2 DSM Business Overview
- 4.1.3 DSM Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DSM Lipids in Human Nutrition Product Portfolio
- 4.1.5 DSM Recent Developments
- 4.2 Polaris
- 4.2.1 Polaris Company Information
- 4.2.2 Polaris Business Overview
- 4.2.3 Polaris Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Polaris Lipids in Human Nutrition Product Portfolio
- 4.2.5 Polaris Recent Developments
- 4.3 ADM
- 4.3.1 ADM Company Information
- 4.3.2 ADM Business Overview
- 4.3.3 ADM Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ADM Lipids in Human Nutrition Product Portfolio
- 4.3.5 ADM Recent Developments
- 4.4 BASF
- 4.4.1 BASF Company Information
- 4.4.2 BASF Business Overview
- 4.4.3 BASF Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BASF Lipids in Human Nutrition Product Portfolio
- 4.4.5 BASF Recent Developments
- 4.5 FMC Corporation
- 4.5.1 FMC Corporation Company Information
- 4.5.2 FMC Corporation Business Overview
- 4.5.3 FMC Corporation Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 FMC Corporation Lipids in Human Nutrition Product Portfolio
- 4.5.5 FMC Corporation Recent Developments
- 4.6 Lonza Group AG
- 4.6.1 Lonza Group AG Company Information
- 4.6.2 Lonza Group AG Business Overview
- 4.6.3 Lonza Group AG Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lonza Group AG Lipids in Human Nutrition Product Portfolio
- 4.6.5 Lonza Group AG Recent Developments
- 4.7 Omega Protein Corporation
- 4.7.1 Omega Protein Corporation Company Information
- 4.7.2 Omega Protein Corporation Business Overview
- 4.7.3 Omega Protein Corporation Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Omega Protein Corporation Lipids in Human Nutrition Product Portfolio
- 4.7.5 Omega Protein Corporation Recent Developments
- 4.8 Cargill
- 4.8.1 Cargill Company Information
- 4.8.2 Cargill Business Overview
- 4.8.3 Cargill Lipids in Human Nutrition Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cargill Lipids in Human Nutrition Product Portfolio
- 4.8.5 Cargill Recent Developments
5 Global Lipids in Human Nutrition Market Scenario by Region
- 5.1 Global Lipids in Human Nutrition Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lipids in Human Nutrition Sales by Region: 2021-2032
- 5.2.1 Global Lipids in Human Nutrition Sales by Region: 2021-2026
- 5.2.2 Global Lipids in Human Nutrition Sales by Region: 2027-2032
- 5.3 Global Lipids in Human Nutrition Revenue by Region: 2021-2032
- 5.3.1 Global Lipids in Human Nutrition Revenue by Region: 2021-2026
- 5.3.2 Global Lipids in Human Nutrition Revenue by Region: 2027-2032
- 5.4 North America Lipids in Human Nutrition Market Facts & Figures by Country
- 5.4.1 North America Lipids in Human Nutrition Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lipids in Human Nutrition Sales by Country (2021-2032)
- 5.4.3 North America Lipids in Human Nutrition Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lipids in Human Nutrition Market Facts & Figures by Country
- 5.5.1 Europe Lipids in Human Nutrition Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lipids in Human Nutrition Sales by Country (2021-2032)
- 5.5.3 Europe Lipids in Human Nutrition Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lipids in Human Nutrition Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lipids in Human Nutrition Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lipids in Human Nutrition Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lipids in Human Nutrition Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lipids in Human Nutrition Market Facts & Figures by Country
- 5.7.1 South America Lipids in Human Nutrition Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lipids in Human Nutrition Sales by Country (2021-2032)
- 5.7.3 South America Lipids in Human Nutrition Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Lipids in Human Nutrition Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lipids in Human Nutrition Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lipids in Human Nutrition Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lipids in Human Nutrition Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lipids in Human Nutrition Sales by Type (2021-2032)
- 6.1.1 Global Lipids in Human Nutrition Sales by Type (2021-2032) & (t)
- 6.1.2 Global Lipids in Human Nutrition Sales Market Share by Type (2021-2032)
- 6.2 Global Lipids in Human Nutrition Revenue by Type (2021-2032)
- 6.2.1 Global Lipids in Human Nutrition Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lipids in Human Nutrition Revenue Market Share by Type (2021-2032)
- 6.3 Global Lipids in Human Nutrition Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lipids in Human Nutrition Sales by Application (2021-2032)
- 7.1.1 Global Lipids in Human Nutrition Sales by Application (2021-2032) & (t)
- 7.1.2 Global Lipids in Human Nutrition Sales Market Share by Application (2021-2032)
- 7.2 Global Lipids in Human Nutrition Revenue by Application (2021-2032)
- 7.2.1 Global Lipids in Human Nutrition Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lipids in Human Nutrition Revenue Market Share by Application (2021-2032)
- 7.3 Global Lipids in Human Nutrition Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lipids in Human Nutrition Value Chain Analysis
- 8.1.1 Lipids in Human Nutrition Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lipids in Human Nutrition Production Mode & Process
- 8.2 Lipids in Human Nutrition Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lipids in Human Nutrition Distributors
- 8.2.3 Lipids in Human Nutrition Customers
9 Global Lipids in Human Nutrition Analyzing Market Dynamics
- 9.1 Lipids in Human Nutrition Industry Trends
- 9.2 Lipids in Human Nutrition Industry Drivers
- 9.3 Lipids in Human Nutrition Industry Opportunities and Challenges
- 9.4 Lipids in Human Nutrition Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst